Cargando…

Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls

Accurate diagnosis at an early stage of infection is essential for the successful management of any contagious disease. The coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is a pandemic that has affected 214 countries affecting mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Premraj, Avinash, Aleyas, Abi George, Nautiyal, Binita, Rasool, Thaha J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690661/
https://www.ncbi.nlm.nih.gov/pubmed/33114057
http://dx.doi.org/10.3390/diagnostics10110866
_version_ 1783614119015874560
author Premraj, Avinash
Aleyas, Abi George
Nautiyal, Binita
Rasool, Thaha J
author_facet Premraj, Avinash
Aleyas, Abi George
Nautiyal, Binita
Rasool, Thaha J
author_sort Premraj, Avinash
collection PubMed
description Accurate diagnosis at an early stage of infection is essential for the successful management of any contagious disease. The coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is a pandemic that has affected 214 countries affecting more than 37.4 million people causing 1.07 million deaths as of the second week of October 2020. The primary diagnosis of the infection is done either by the molecular technique of RT-qPCR by detecting portions of the RNA of the viral genome or through immunodiagnostic tests by detecting the viral proteins or the antibodies produced by the host. As the demand for the test increased rapidly many naive manufacturers entered the market with novel kits and more and more laboratories also entered the diagnostic arena making the test result more error-prone. There are serious debates globally and regionally on the sensitivity and specificity of these tests and about the overall accuracy and reliability of the tests for decision making on control strategies. The significance of the test is also complexed by the presence of asymptomatic carriers, re-occurrence of infection in cured patients as well as by the varied incubation periods of the infection and shifting of the viral location in the host tissues. In this paper, we review the techniques available for SARS-CoV-2 diagnosis and probable factors that can reduce the sensitivity and specificity of the different test methods currently in vogue. We also provide a checklist of factors to be considered to avoid fallacious practices to reduce false positive and false negative results by the clinical laboratories.
format Online
Article
Text
id pubmed-7690661
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76906612020-11-27 Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls Premraj, Avinash Aleyas, Abi George Nautiyal, Binita Rasool, Thaha J Diagnostics (Basel) Review Accurate diagnosis at an early stage of infection is essential for the successful management of any contagious disease. The coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is a pandemic that has affected 214 countries affecting more than 37.4 million people causing 1.07 million deaths as of the second week of October 2020. The primary diagnosis of the infection is done either by the molecular technique of RT-qPCR by detecting portions of the RNA of the viral genome or through immunodiagnostic tests by detecting the viral proteins or the antibodies produced by the host. As the demand for the test increased rapidly many naive manufacturers entered the market with novel kits and more and more laboratories also entered the diagnostic arena making the test result more error-prone. There are serious debates globally and regionally on the sensitivity and specificity of these tests and about the overall accuracy and reliability of the tests for decision making on control strategies. The significance of the test is also complexed by the presence of asymptomatic carriers, re-occurrence of infection in cured patients as well as by the varied incubation periods of the infection and shifting of the viral location in the host tissues. In this paper, we review the techniques available for SARS-CoV-2 diagnosis and probable factors that can reduce the sensitivity and specificity of the different test methods currently in vogue. We also provide a checklist of factors to be considered to avoid fallacious practices to reduce false positive and false negative results by the clinical laboratories. MDPI 2020-10-23 /pmc/articles/PMC7690661/ /pubmed/33114057 http://dx.doi.org/10.3390/diagnostics10110866 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Premraj, Avinash
Aleyas, Abi George
Nautiyal, Binita
Rasool, Thaha J
Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
title Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
title_full Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
title_fullStr Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
title_full_unstemmed Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
title_short Nucleic Acid and Immunological Diagnostics for SARS-CoV-2: Processes, Platforms and Pitfalls
title_sort nucleic acid and immunological diagnostics for sars-cov-2: processes, platforms and pitfalls
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690661/
https://www.ncbi.nlm.nih.gov/pubmed/33114057
http://dx.doi.org/10.3390/diagnostics10110866
work_keys_str_mv AT premrajavinash nucleicacidandimmunologicaldiagnosticsforsarscov2processesplatformsandpitfalls
AT aleyasabigeorge nucleicacidandimmunologicaldiagnosticsforsarscov2processesplatformsandpitfalls
AT nautiyalbinita nucleicacidandimmunologicaldiagnosticsforsarscov2processesplatformsandpitfalls
AT rasoolthahaj nucleicacidandimmunologicaldiagnosticsforsarscov2processesplatformsandpitfalls